Cita APA

Cohen, H., Doré, C. J., Clawson, S., Hunt, B. J., Isenberg, D., Khamashta, M., & Muirhead, N. (2015). Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: A prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus.

Citación estilo Chicago

Cohen, H., C J. Doré, S. Clawson, B J. Hunt, D. Isenberg, M. Khamashta, y N. Muirhead. "Rivaroxaban in Antiphospholipid Syndrome (RAPS) Protocol: A Prospective, Randomized Controlled Phase II/III Clinical Trial of Rivaroxaban Versus Warfarin in Patients With Thrombotic Antiphospholipid Syndrome, With or Without SLE." Lupus 2015.

Cita MLA

Cohen, H., et al. "Rivaroxaban in Antiphospholipid Syndrome (RAPS) Protocol: A Prospective, Randomized Controlled Phase II/III Clinical Trial of Rivaroxaban Versus Warfarin in Patients With Thrombotic Antiphospholipid Syndrome, With or Without SLE." Lupus 2015.